Lung Injury Clinical Trial
Official title:
Effects of Sustained Inflation or Positive Pressure Ventilation on Release of Adrenomedullin in Preterm Infants With Respiratory Failure at Birth
In this clinical trial the Investigators aimed to assess the Adrenomedullin (AM) release in urine and plasma in preterm infants undergoing Sustained Inflation or Positive Pressure Ventilation at birth to manage respiratory failure.
Background and objectives: The respiratory management in the DR may play an important role in
the development and prevention of lung injury. The sustained lung inflation (SI) is a
promising approach to facilitate cardio-respiratory transition, but currently, although it
has been shown to decrease the duration of MV, seems not to guarantee relevant benefits
compared to Positive Pressure Ventilation (PPV). In order to clarify the impact of these two
different approaches on lung tissues, this study measures Adrenomedullin (AM), which is a
biomarker involved in lung development.
Methods: we conducted a prospective case control-study in a cohort of very low birth weight
(VLBW) infants (< 1500 g) of 28+0-30+6 weeks of gestational age (GA), who received SI or PPV
during stabilization in DR.
Exclusion criteria were major malformations (i.e. congenital heart disease, cerebral, lung
and abdominal malformations), fetal hydrops, lack of parental consent and need for
endotracheal intubation at birth.
Blood samples for AM measurement were collected at birth from the arterial umbilical cord
before resuscitation maneuvers, then at 1 hour from birth and at 24 hours from birth.
Moreover, urine samples were collected, in correspondence with the first urine emission while
in NICU and at 24 hours of life.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05054270 -
Efficacy of Lung Ultrasound in Monitoring Fluid Resuscitation in Chest Trauma Patients
|
||
Not yet recruiting |
NCT04470297 -
Melatonin Agonist on Hospitalized Patients With Confirmed or Suspected COVID-19
|
Phase 2 | |
Not yet recruiting |
NCT01184313 -
Acute Lung Injury After Aortic Valve Surgery
|
N/A | |
Not yet recruiting |
NCT06446544 -
Functional Residual Capacity and Alveolar Recruitment in Single-lung Ventilation: a Randomized Study
|
N/A | |
Not yet recruiting |
NCT06296173 -
Open Lung Protective Extubation Following General Anesthesia
|
N/A | |
Not yet recruiting |
NCT03661502 -
Effect of Variable Volume Ventilation on Lung Compliance
|
N/A | |
Recruiting |
NCT04296071 -
Neutrophil Phenotypic Profiling and Acute Lung Injury in Patients After Cardiopulmonary Bypass (CPB)
|
||
Completed |
NCT04645316 -
The Effect of Sevoflurane and Desflurane on Clara Cell Protein on the Lung
|
N/A | |
Recruiting |
NCT02299921 -
Effect of Alcohol and Drugs of Abuse on Immune Function in Critically Ill Patients With Respiratory Failure
|
||
Recruiting |
NCT05559970 -
Inhalational Sedation and Mechanical Power
|
N/A | |
Completed |
NCT03581006 -
Food Intake REstriction for Health OUtcome Support and Education (FIREHOUSE) Trial
|
||
Recruiting |
NCT05228717 -
Point-of-care Lung Ultrasound (POCUS)-Integrated Study of Admitted Patients With COVID-19
|
||
Recruiting |
NCT04372953 -
Positive End-Expiratory Pressure (PEEP) Levels During Resuscitation of Preterm Infants at Birth (The POLAR Trial).
|
N/A | |
Not yet recruiting |
NCT05363085 -
The Cerebral-Respiratory Interaction in Controlled Mechanically Ventilated Neurosurgical Patients. (The CeRes-CMV Study)
|
||
Recruiting |
NCT02444858 -
Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Paraquat Poisoning Induced Lung Injury
|
Phase 1/Phase 2 | |
Completed |
NCT03924206 -
Hazardous Surgical Smoke: Risk Assessment and Evaluation of a New Smoke Extractor System in the Surgical Unit
|
||
Recruiting |
NCT06416709 -
Stem Cell Treatment for Lung Injury Caused by Major Infectious Diseases
|
Phase 1/Phase 2 | |
Withdrawn |
NCT01939067 -
Infant Pulmonary Mechanics: High Flow Nasal Cannula Versus Nasal CPAP
|
Phase 1 | |
Recruiting |
NCT05401474 -
Individualization Flow in Patients Treated With High Flow Nasal Therapy (iFLOW)
|
N/A | |
Not yet recruiting |
NCT05381415 -
Effect on Bronchodilation Response and Ventilation Heterogeneity of Different Inhalation Volumes in COPD
|